589 results on '"Misu, Tatsuro"'
Search Results
2. Case Report: An Adult Case of Poretti-Boltshauser Syndrome Diagnosed by Medical Checkup
3. White blood cell count profiles in anti-aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein antibody-associated disease
4. Stochastic models for the onset and disease course of multiple sclerosis
5. Dynamic changes in patient admission and their disabilities in multiple sclerosis and neuromyelitis optica: A Japanese nationwide administrative data study
6. Efficacy and safety of inebilizumab in Asian participants with neuromyelitis optica spectrum disorder: Subgroup analyses of the N-MOmentum study
7. Associations between neuromyelitis optica spectrum disorder, Sjögren's syndrome, and conditions with electrolyte disturbances
8. Relapse activity in the chronic phase of anti-myelin-oligodendrocyte glycoprotein antibody-associated disease
9. Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSD
10. Case report: An adult case of Poretti-Boltshauser syndrome diagnosed by medical checkup.
11. Myelin oligodendrocyte glycoprotein antibody‐associated disorders: An overview
12. Clinicopathological findings of patient with MOG antibodies detected only in cerebrospinal fluid
13. Review for "Correlation of GABA+ levels in the medial prefrontal cortex and circulating follicular helper T cells in neuromyelitis optica spectrum disorder patients with cognitive impairment"
14. Dynamic Changes in Patient Admission and Their Disabilities in Multiple sclerosis and Neuromyelitis Optica: A Japanese Nationwide Administrative Data Study
15. Impact of comorbid Sjögren syndrome in anti-aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders
16. CH50 as a putative biomarker of eculizumab treatment in neuromyelitis optica spectrum disorder
17. Myelin oligodendrocyte glycoprotein-IgG-positive, steroid-responsive combined central and peripheral demyelination with recurrent peripheral neuropathy
18. Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody
19. Myelin oligodendrocyte glycoprotein antibody‐associated disorders: An overview.
20. White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments
21. Safety and efficacy of rituximab in neuromyelitis optica spectrum disorders (RIN-1 study): a multicentre, randomised, double-blind, placebo-controlled trial
22. Microfibrillar-associated protein 4 as a potential marker of acute relapse in inflammatory demyelinating diseases of the central nervous system: Pathological and clinical aspects
23. Anti-aquaporin-4 antibody (AQP4-IgG) and anti-myelin oligodendrocyte glycoprotein antibody (MOG-IgG) in the cerebrospinal fluid
24. Distal Chronic Inflammatory Demyelinating Polyneuropathy Following COVID-19 Vaccination in a Patient with Solitary Plasmacytoma: A Case Report and Literature Review
25. Spinal Cord Infarction in an Adolescent with Protein S Deficiency: A Case Report and Literature Review
26. GRP78 Antibodies Are Associated With Blood-Brain Barrier Breakdown in Anti–Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disorder
27. Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders
28. Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat
29. Progressive patterns of neurological disability in multiple sclerosis and neuromyelitis optica spectrum disorders
30. Retrospective comparison clinical presentation and outcome of Natalizumab and Fingolimod-associated PML (P7-3.004)
31. Diagnostic implications of MOG-IgG detection in sera and cerebrospinal fluids
32. Microfibrillar-associated Protein 4 as Potential Marker of Acute Relapse in Inflammatory Demyelinating Diseases of the Central Nervous System: Pathological and Clinical Aspects
33. Paths to hippocampal damage in neuromyelitis optica spectrum disorders
34. Complement-dependent cytotoxicity of human autoantibodies against myelin oligodendrocyte glycoprotein
35. Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes
36. Paraneoplastic Neuromyelitis Optica Spectrum Disorder Related to Glucose-regulated Protein 78 (GRP78) Autoantibodies in a Patient with Lynch Syndrome-associated Colorectal Cancer
37. Reply to the Letter "Reversible Vasoconstriction Syndrome is a Complication of SARS-CoV-2 Infection/Vaccination Rather Than That of Leigh Syndrome"
38. Adult-onset Leigh Syndrome with a m.9176 T>C Mutation Manifested as Reversible Cerebral Vasoconstriction Syndrome
39. Time-Dependent Analysis of Sicca Symptoms and Anti-Ro/SSA and Anti-La/SSB Antibodies in Patients with AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder
40. Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica
41. Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies
42. Fingolimod-associated PML with mild IRIS in MS: A clinicopathologic study
43. Case Report: Vertebro-vertebral arteriovenous fistula showing symptoms mimicking ALS: Diagnostic imaging supports accurate differentiation between ALS and mimicking conditions
44. Review for "A tyrosine‐based YXXΦ motif regulates the degradation of aquaporin‐4 via both lysosomal and proteasomal pathways and is functionally inhibited by a ten‐amino‐acid sequence within its C‐terminus"
45. The Immediate Onset of Isolated and Unilateral Abducens Nerve Palsy Associated with COVID-19 Infection: A Case Report and Literature Review
46. Follow-up of retinal thickness and optic MRI after optic neuritis in anti-MOG antibody-associated disease and anti-AQP4 antibody-positive NMOSD
47. MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy
48. Myelin oligodendrocyte glycoprotein immunoglobulin G‐associated disease: An overview
49. MOG Antibody-Associated Disorders Following SARS-CoV-2 Vaccination: A Case Report and Literature Review
50. Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.